Circ_0081143 Contributes to Gastric Cancer Malignant Development and Doxorubicin Resistance by Elevating the Expression of YES1 by Targeting mziR-129-2-3p-Reference-Cited by-同舟云学术

Circ_0081143 Contributes to Gastric Cancer Malignant Development and Doxorubicin Resistance by Elevating the Expression of YES1 by Targeting mziR-129-2-3p

Published:2022-06-10 Issue:6 Volume:16 Page:861-874
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Ou Wenting¹,Lin Lin¹,Chen Rihong¹,Xu Qingwen¹,Zhou Caijin¹

Affiliation:

1. Departments of 1Medical Oncology and 2Gastrointestinal Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China

Funder

Chengdu Municipal Health Commission Project

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2022/016/gnl-16-6-861.pdf

Reference28 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Cancer statistics, 2017

3. Pathogenesis of Gastric Cancer: Genetics and Molecular Classification

4. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype

5. Differences in the multimodal treatment of gastric cancer: East versus west

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel role of circRNAs in the drug resistance of gastric cancer: regulatory mechanisms and future for cancer therapy;Frontiers in Pharmacology;2024-09-09

2. miR-129-2-3p mediates LPS-induced macrophage polarization and ferroptosis by targeting the SMAD3-GPX4 axis;Gene;2024-02

3. miR-129-2-3p inhibits colon cancer cell proliferation by down-regulating the expression of BZW1;Arab Journal of Gastroenterology;2024-02

4. Molecular Mechanism Analysis of the Effect of Hederagenin Combined with L-OHP on Chemosensitivity of AGS/L-OHP Based on Network Pharmacology;Current Computer-Aided Drug Design;2024-01-11

5. Feasibility evaluation of hsa_circ_0005480 as an auxiliary diagnostic and prognostic indicator for gastric cancer;Biomarkers in Medicine;2023-07